ad image

Rezpegaldesleukin

1 / 1
Nektar Therapeutics
Drug Development

Nektar Therapeutics Receives Fast Track Designation for the Treatment of Moderate-to-Severe Atopic Dermatitis

Nektar Therapeutics

PR-02-25-NI-07Feb 10, 2025
1 / 1